Dog Heartworm Disease: Prevention, Welfare Impact, and Treatment

Heartworm is a serious parasitic disease spread by mosquitoes that damages the heart, lungs, and blood vessels of infected dogs. Prevention is far simpler and less risky than treatment.

Key Facts

Heartworm (Dirofilaria immitis) is transmitted by mosquito bites and causes larvae to develop into worms in the heart and pulmonary vessels
Dogs are the primary host — worms can reach 30 cm in length and live for 5-7 years
Heartworm disease is endemic across much of the Americas, southern Europe, Australia, and Asia
Clinical signs progress from subtle cough to exercise intolerance, weight loss, and heart failure
Treatment exists but is expensive, involves restricted rest for months, and carries significant risk
Monthly preventive medications are highly effective when given consistently year-round

Welfare Considerations

Heartworm disease causes progressive, often painful deterioration of cardiovascular function. In later stages dogs struggle to breathe, cannot exercise, and experience the distress of cardiac failure. The treatment itself — arsenic-based compounds that kill adult worms — involves a period of enforced cage rest to prevent pulmonary embolism from dying worms, causing additional welfare challenges. Prevention is dramatically superior in welfare terms: safe, effective, and sparing dogs from months of illness and treatment. In endemic areas, regular preventive medication is an ethical obligation for dog owners.

What You Can Do

Give year-round heartworm prevention medication as recommended by your vet in endemic areas
Test your dog annually for heartworm — early detection allows simpler treatment
Do not assume your area is heartworm-free without veterinary guidance
If treating an infected dog, follow restricted exercise protocols to reduce pulmonary embolism risk
Support mosquito control efforts in communities where heartworm is highly prevalent